Peripheral artery disease (PAD) is a growing cardiovascular condition caused by the narrowing or blockage of arteries that supply blood to the limbs, particularly the legs. Increasing prevalence of diabetes, obesity, cardiovascular disorders, and an aging population is driving demand for advanced treatment options. Innovative procedures such as peripheral angioplasty, peripheral stents, and critical limb ischemia treatment are improving blood flow restoration and reducing the risk of severe complications, including limb amputation. These advancements are significantly contributing to the expansion of the U.S. Peripheral Artery Disease Market, as healthcare providers increasingly adopt minimally invasive vascular interventions.

The U.S. peripheral artery disease market size was valued at USD 2.35 billion in 2024 and is projected to grow at a CAGR of 4.8% from 2025 to 2034. The market is expected to expand from USD 2.46 billion in 2025 to USD 3.76 billion by 2034.

Rising Importance of Peripheral Angioplasty

Peripheral angioplasty has become one of the most widely adopted minimally invasive procedures for treating PAD. The procedure involves inserting a catheter with a small balloon into the narrowed artery and expanding it to restore blood flow. This technique helps improve circulation, reduce symptoms, and enhance mobility among patients experiencing arterial blockages.

Compared with traditional surgical bypass procedures, peripheral angioplasty offers several advantages, including:

• Reduced recovery time
• Lower procedural risks
• Shorter hospital stays
• Improved patient comfort
• Ability to treat multiple arterial blockages

The growing preference for minimally invasive vascular procedures is increasing the adoption of peripheral angioplasty across hospitals and specialized cardiovascular centers. Technological advancements, including drug-coated balloons and improved catheter designs, are further enhancing procedural effectiveness and long-term outcomes.

Role of Peripheral Stents in PAD Treatment

Peripheral stents play a crucial role in maintaining vessel openness after angioplasty procedures. These small mesh-like devices are implanted inside narrowed arteries to provide structural support and prevent vessel re-narrowing.

Modern peripheral stent technologies include self-expanding stents, balloon-expandable stents, and drug-eluting stents designed to improve durability and reduce restenosis risk. These innovations have expanded treatment options for patients with complex peripheral arterial blockages.

Key benefits of peripheral stents include:

• Sustained improvement in blood circulation
• Reduced risk of arterial re-occlusion
• Improved walking ability and quality of life
• Effective treatment for long lesions and challenging anatomies

The increasing adoption of advanced vascular devices is supporting growth in the U.S. Peripheral Artery Disease Market. Continuous product development and improvements in stent materials are helping physicians achieve better clinical outcomes for PAD patients.

Advancements in Critical Limb Ischemia Treatment

Critical limb ischemia treatment represents one of the most important areas of PAD management. Critical limb ischemia (CLI) is an advanced stage of peripheral artery disease characterized by severe arterial blockages, persistent pain, ulcers, and reduced blood supply to the limbs. Without timely intervention, CLI can lead to tissue damage and possible amputation.

Treatment approaches for critical limb ischemia include:

• Peripheral angioplasty
• Peripheral stent placement
• Atherectomy procedures
• Surgical bypass procedures
• Wound care management
• Drug-based therapies

The growing focus on limb preservation is encouraging healthcare providers to adopt advanced endovascular techniques. Early diagnosis and timely intervention are becoming increasingly important in reducing complications and improving patient outcomes.

Technology Innovations Driving Market Growth

Technological advancements are transforming PAD diagnosis and treatment. Improved imaging systems, advanced catheter technologies, and next-generation vascular devices are enabling physicians to perform more precise procedures.

Innovations such as drug-coated balloons and drug-eluting stents are helping reduce restenosis and improve long-term vessel performance. Additionally, advancements in artificial intelligence (AI)-based imaging and digital healthcare platforms are supporting faster diagnosis and better treatment planning.

The integration of these technologies is expected to create new opportunities within the U.S. Peripheral Artery Disease Market by improving accessibility and expanding treatment options.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/us-peripheral-artery-disease-market

Key Players

• Abbott
• BD
• Boston Scientific Corporation
• Cook Medical
• Inari Medical (Stryker)
• Koninklijke Philips N.V.,
• Medtronic
• Penumbra, Inc.
• Shockwave Medical, Inc.
• W. L. Gore & Associates, Inc.

Future Outlook

The future of PAD management will focus on early diagnosis, minimally invasive interventions, and advanced vascular technologies. Peripheral angioplasty, peripheral stents, and critical limb ischemia treatment will continue to play a vital role in improving patient outcomes and reducing disease complications.

As healthcare providers increasingly prioritize limb preservation and minimally invasive treatment approaches, the U.S. Peripheral Artery Disease Market is expected to witness steady growth through 2034. Continued innovation in vascular devices, improved treatment accessibility, and growing awareness of PAD management will further strengthen the adoption of advanced peripheral artery disease therapies.

More Trending Latest Reports By Polaris Market Research:

Apoptosis Assay Market

LED Oral Care Kits Market

Handheld Imagers Market

Age-Related Macular Degeneration (Amd) Market

Immune Health Supplements Market

Trachoma Treatment Market

Hypodermic Syringes and Needles market for Animal Health

U.S. Antibiotics Market